| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. My69z: 3 yrs ago -- ICI Agreement with major institution (6222)  (8) |
| 2. biloxiblues: Summary of Leronlimab’s Path and Regulatory (2436) (9) |
| 3. KenChowder: Note from Max Lataillade on LinkedIn in response (2400) (39) |
| 4. Evil Rabbit: I’ve repeatedly griped/whined/complained, (2192) (21) |
| 5. My69z: Dr. Sacha Project End Date 30-June-2025: "These (2189) (9) |
| 6. Cycl2R: I don’t believe it has been noted here that the (2121) (12) |
| 7. MJS719: Thank you brentie for the reminder of how (2116) (10) |
| 8. MGK_2: ohm, considering your last line, "A combination (2040) (6) |
| 9. Figgs: Do we have data from our 2021 trial: Leronlimab (1963) (5) |
| 10. My69z: I now think like some said --- even before mTNBC (1837) (5) |
| 11. Scuffler: Understood. But I think the lack of more (1753) (8) |
| 12. Scuffler: In response to the conversation about PR- Been (1751) (20) |
| 13. MGK_2: I think you're spot on mfglola. I wrote (1459) (13) |
| 14. MGK_2: I have a question on a (1433) (2) |
| 15. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (1309) |
| 16. Wharfrat: David Dalton comments on LI (same day as last (1235) (10) |
| 17. Chasing Stars: Getting started on Investors Hangout. Are you (1109) (14) |
| 18. sjacobs26: My calculator broke on the third oncology (906) (23) |
| 19. z_smith01: We have talked about this a lot over the years. (800) (33) |
| 20. mightycydy: New post by Dr. Max Lataillade re: Leronlimab (788) (31) |
| 21. My69z: Employment Agreement between CytoDyn Inc. and (774) (6) |
| 22. ScottyDoggs: Someone else brought this up on another website (770) (5) |
| 23. My69z: The global chemotherapy market was valued at USD (759) (7) |
| 24. sean007: An individual went conservative on this (736) (9) |
| 25. My69z: Few weeks ago i said if eventually the FDA goes (736) (3) |
| 26. mikeyt1818: Great post. That reminds me of late 2018 and (735) (4) |
| 27. USS JOHNSTON: Great find re Dr Max's linkedin post, mighty, and (722) (26) |
| 28. ohm20: "Brain cancer patient DJ Daniel faces 3 new (713) (9) |
| 29. My69z: Multiple loose-end trials. CFO blocked for 1 yr @ (699) (5) |
| 30. USS JOHNSTON: Just an FYI, I messaged someone on Linked-in last (685) (21) |
| 31. Evil Rabbit: Cytodyn is not a buy-out. Cytodyn is a build-out. (684) (22) |
| 32. skezan: I guess the FDA approval of lenacapavir explains (678) (15) |
| 33. dfwl28: "An individual went conservative on this (678) (12) |
| 34. My69z: Past BTD application -- WOW !! All patients in (676) (4) |
| 35. DJknows: Nice post on LinkedIn by Max Latallaide entitled: (672) (8) |
| 36. Evil Rabbit: To me, not enough data in 3 - 12 months to (671) (15) |
| 37. Mr3Putt: 134eP - Observed Survival Following Treatment (667) (11) |
| 38. misiu143: Excellent point Evil , During quiet period , or (658) (8) |
| 39. mfglola: prostate cancer is now in stage pre-clinical . (657) (5) |
| 40. Evil Rabbit: It’s not so much a lack of PRs for me, it’s a (654) (7) |
| 41. Albert364: Love International Group, Inc. (LOVV) is a (651) |
| 42. Rosner: Short Interest Report As of Sat, Aug 3, '13 (648) |
| 43. Blindspot: News on the other board. Looks like about $6.5 (647) (1) |
| 44. My69z: Gilead -- 2 drugs: Tuesday, April 29, 2025 U.S. (645) (7) |
| 45. Evil Rabbit: I told you to try the brownies on the blue plate, (645) (15) |
| 46. WUM: A link from stocktwits: new article in JAIDS (640) (18) |
| 47. ohm20: Ohm20, how does this compare to Leronlimab? Any (639) (23) |
| 48. Riztheinvestor: Hey everyone, I just want to take a moment to (629) (20) |
| 49. Stratego: Why not use the word “cure”? (628) (1) |
| 50. MGK_2: "The Company continues to be on track financially (627) (7) |
